Gland Pharma Q2FY25 results: Net profit falls 15.7% to Rs 164 crore

Quick Summary:

The company reported consolidated net profit of Rs 164 crore ($19.5 million) for the quarter ended Sept.30, a 15.

The company said its overall revenue growth was hurt by temporary production issues at Cenexi.

Sales from the US, its biggest market, increased 3 per cent, and sales from its other markets of Canada, Australia, and New Zealand rose 45 per cent, the company said.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaAustraliaCanadaNew Zealand

Topics: Gland Pharma Gland Pharma Q2 revenue Gland Pharma Q2 profit Gland Pharma Q2 results

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-11-04 @ 19:37:19 (2 weeks ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 384 words

Reading Time: 3 minutes read

Sentences: 19 lines

Sentence Length: 21 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 23398065

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 300 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions